Membrane Targeting and Retargeting of Polarity Proteins
极性蛋白的膜靶向和重靶向
基本信息
- 批准号:9897539
- 负责人:
- 金额:$ 30.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdherens JunctionAllosteric RegulationApicalBindingBiologicalBiological ModelsBrain Hypoxia-IschemiaCell PolarityCell membraneCellsChargeComplexCultured CellsCytosolDataDefectDevelopmentDiseaseDrosophila genomeDrosophila genusDrosophila inturned proteinE-CadherinElectrostaticsEnsureEpithelialEpitheliumGenetic ModelsHuman GenomeHypoxiaIntegral Membrane ProteinInvertebratesIschemiaMalignant NeoplasmsMammalian CellMediatingMembraneMolecularNaturePAR-6 proteinPathologicPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesPhosphatidylinositolsPhospholipidsPhosphorylationPhosphotransferasesPlasma CellsPlayProteinsRecoveryRegulationResearchRoleStressSurfaceTertiary Protein StructureTimeTissuesVertebratesbasebeta catenincell cortexhuman diseasein vivonovelprotein complexprotein protein interactionrecruittumorigenesis
项目摘要
Membrane Targeting and Retargeting of Polarity Proteins
ABSTRACT
Establishing and maintaining apical-basal polarity is essential for epithelial tissue integrity and function
under both normal and stressed conditions. A group of so-called polarity proteins play essential and
conserved functions in regulating cell polarity in both invertebrates and vertebrates. One key feature of all
polarity proteins is that association with plasma membrane (PM) or cell cortex is critical for their in vivo
functions. With few exceptions, most polarity proteins are assumed to be localized to PM/cell cortex through
protein-protein interactions. Regulatable molecular mechanisms underlying the potential direct interaction
between PM and majority of polarity proteins have long been elusive. Polybasic domains that are rich in
positively charged Arg and Lyn residues have a well-established role in PM-specific targeting, based on its
electrostatic interactions with negatively charged polyphosphoinositides PI4P and PIP2 that are uniquely
enriched on the PM inner surface. However, for decades functional studies on polybasic domain in PM
targeting have been limited to a small number of proteins of diverse functions and no polybasic domains had
been characterized in any of the polarity proteins.
We recently identified Lgl as the first polarity protein that contains an evolutionarily conserved and
phosphorylatable polybasic domain whose electrostatic binding to PI4P and PIP2 on the PM directly mediate
the PM localization of Lgl. In this proposal we have identified that multiple additional polarity proteins, as well
as hundreds to thousands of proteins in Drosophila and human genomes, also contain potential polybasic
domains. We will use both Drosophila and cultured mammalian cells to investigate the hypothesis that
electrostatic binding between polybasic domain and plasma membrane serves a key regulatable molecular
mechanism for controlling the subcellular localizations of multiple polybasic polarity proteins. We will first
confirm the electrostatic binding of PM by multiple polybasic polarity proteins. More importantly, we will
investigate the molecular mechanisms such as phosphorylation, allosteric regulation and coincident protein
interactions that may control the direct binding between PM and polybasic polarity proteins to achieve their
polarized subcellular localization and activations. Finally, our research highlighted for the first time that hypoxia
and depletion of ATP acutely and reversibly inhibit polybasic domain proteins PM targeting through depleting
PI4P and PIP2 on the PM, revealing a previously unappreciated but biologically significant challenge for cells to
retarget polybasic polarity proteins to original PM domains after hypoxia/ischemia. We will focus on identifying
mechanisms that actively direct the retargeting of polybasic polarity proteins to their original PM domains.
Our research aims to establish a new paradigm regarding how regulatable binding between polybasic
domains and PM serves as a fundamental mechanism to integrate the protein-protein interactions in achieving
polarized PM targeting of polarity protein under both normal and stress conditions.
极性蛋白的膜靶向和重靶向
摘要
建立和维持顶-底极性对上皮组织的完整性和功能至关重要
在正常和压力条件下。一组所谓的极性蛋白质起着重要作用,
在无脊椎动物和脊椎动物中调节细胞极性的保守功能。所有的一个关键特征
极性蛋白的一个重要特征是与质膜(PM)或细胞皮层的结合对于它们在体内的表达至关重要。
功能协调发展的除了少数例外,大多数极性蛋白质被认为是定位于PM/细胞皮层,通过
蛋白质相互作用潜在直接相互作用的可调控分子机制
PM和大多数极性蛋白之间的联系一直是难以捉摸的。多基域富含
带正电荷的Arg和林恩残基在PM特异性靶向中具有良好的作用,这是基于其
与带负电荷的聚磷酸肌醇PI 4P和PIP 2的静电相互作用,
在PM内表面富集。然而,几十年来,对PM中多碱基结构域的功能研究
靶向仅限于少数不同功能的蛋白质,
在任何一种极性蛋白质中都有特征。
我们最近鉴定出Lgl是第一个含有进化上保守的和
可磷酸化的多元结构域,其与PM上的PI 4P和PIP 2的静电结合直接介导
Lgl的PM定位。在这个建议中,我们已经确定了多种额外的极性蛋白,以及
果蝇和人类基因组中的数百到数千种蛋白质,
域.我们将使用果蝇和培养的哺乳动物细胞来研究这一假设,
多碱基结构域与质膜之间的静电结合是一个关键的可调控分子,
控制多种多元极性蛋白亚细胞定位的机制。我们将首先
证实了PM与多种多元极性蛋白的静电结合。更重要的是,我们将
研究磷酸化、变构调节和重合蛋白等分子机制
可以控制PM和多元极性蛋白质之间的直接结合以实现其功能的相互作用。
极化的亚细胞定位和激活。最后,我们的研究首次强调了缺氧
ATP的耗竭通过耗竭多碱性结构域蛋白PM靶向,
PM上的PI 4P和PIP 2,揭示了细胞在细胞增殖中以前未被认识到但具有生物学意义的挑战。
缺氧/缺血后将多元极性蛋白重新靶向原始PM结构域。我们将集中精力识别
主动引导多元极性蛋白重新靶向其原始PM结构域的机制。
我们的研究旨在建立一个新的范式,关于多元之间如何可调控的结合
结构域和PM作为整合蛋白质-蛋白质相互作用的基本机制,实现
在正常和胁迫条件下极性蛋白的极化PM靶向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yang Hong其他文献
Yang Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yang Hong', 18)}}的其他基金
Plasma Membrane Targeting and Retargeting of Polarity Proteins
极性蛋白的质膜靶向和重靶向
- 批准号:
10657770 - 财政年份:2017
- 资助金额:
$ 30.31万 - 项目类别:
Regulation of Adherens Junction Trafficking by Polarity Proteins
极性蛋白对粘附连接运输的调节
- 批准号:
8291023 - 财政年份:2010
- 资助金额:
$ 30.31万 - 项目类别:
Regulation of Adherens Junction Trafficking by Polarity Proteins
极性蛋白对粘附连接运输的调节
- 批准号:
8475615 - 财政年份:2010
- 资助金额:
$ 30.31万 - 项目类别:
Regulation of Adherens Junction Trafficking by Polarity Proteins
极性蛋白对粘附连接运输的调节
- 批准号:
8075429 - 财政年份:2010
- 资助金额:
$ 30.31万 - 项目类别:
Regulation of Adherens Junction Trafficking by Polarity Proteins
极性蛋白对粘附连接运输的调节
- 批准号:
7779016 - 财政年份:2010
- 资助金额:
$ 30.31万 - 项目类别:
Regulation of Adherens Junction Trafficking by Polarity Proteins
极性蛋白对粘附连接运输的调节
- 批准号:
8665969 - 财政年份:2010
- 资助金额:
$ 30.31万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Research Grant














{{item.name}}会员




